Cardiff Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CRDF Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
30 Jul 25	BuyUS$710,500	Gary Pace	Individual		290,000	US$2.45

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CRDF?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,658,142	2.43%
Institutions	24,679,788	36.1%
General Public	42,031,966	61.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 34.99% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.82%	BlackRock, Inc.	3,981,387	US$7.6m	-1.54%	no data
4.18%	Vanguard Capital Management, LLC	2,855,966	US$5.4m	0%	no data
3.87%	Laurion Capital Management LP	2,646,738	US$5.0m	0%	0.45%
3.53%	Pfizer Venture Investments LLC	2,411,575	US$4.6m	0%	1.63%
2.58%	Acorn Bioventures	1,762,084	US$3.3m	-10.2%	1.05%
2.34%	Geode Capital Management, LLC	1,599,663	US$3.0m	5.03%	no data
1.97%	Gary Pace	1,345,676	US$2.6m	0%	no data
1.76%	Franklin Resources, Inc.	1,205,803	US$2.3m	0%	no data
1.74%	State Street Global Advisors, Inc.	1,186,947	US$2.3m	-0.39%	no data
1.35%	William Blair Investment Management, LLC	922,407	US$1.8m	-52.7%	no data
0.87%	F. L. Putnam Investment Management Co.	595,127	US$1.1m	-0.03%	0.01%
0.72%	Northern Trust Global Investments	493,205	US$937.1k	6.81%	no data
0.65%	Vanguard Fiduciary Trust Company	446,225	US$847.8k	-0.21%	no data
0.64%	Vanguard Portfolio Management, LLC	437,214	US$830.7k	0%	no data
0.59%	UBS Asset Management AG	400,576	US$761.1k	358%	no data
0.44%	BNY Asset Management	303,428	US$576.5k	-7.77%	no data
0.37%	XTX Markets Limited	250,222	US$475.4k	14.1%	0.01%
0.3%	Two Sigma Investments, LP	206,990	US$393.3k	-71.5%	no data
0.24%	Charles Schwab Investment Management, Inc.	164,708	US$312.9k	-12.7%	no data
0.2%	Avestar Capital, LLC	136,145	US$258.7k	0%	0.01%
0.18%	Citadel Advisors LLC	125,566	US$238.6k	6.24%	no data
0.18%	GSA Capital Partners LLP	123,008	US$233.7k	-41.7%	0.01%
0.17%	Lale White	113,788	US$216.2k	0%	no data
0.16%	AlphaCore Capital LLC	108,426	US$206.0k	-5.24%	no data
0.15%	Renaissance Technologies LLC	101,253	US$192.4k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/31 01:01
End of Day Share Price	2026/05/29 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cardiff Oncology, Inc. is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Paul Knight	Brean Capital Historical (Janney Montgomery)
Bryan Brokmeier	Cantor Fitzgerald & Co.
Gum-Ming Lowe	Craig-Hallum Capital Group LLC